FAQs

Answers to Your Questions

Qi601 is a safe, non-living product made from a heat-treated probiotic (Lactobacillus fermentum) that naturally clumps together. It is taken orally and is taken orally. In laboratory studies on human colonic epithelial cells, CaCO2, Qi601 selectively binds microplastics and nanoplastics preventing them from attaching to the human cells.

Qi601 works by forming a protective biofilm shield; It acts like a sponge or filter, binding
harmful plastic particles.

Qi601 is made of large, greater than 200 microns aggregates of an inactivated probiotic. Generally speaking, larger particles of greater than 1 micron are generally too larger to pass across the gut lining.

Microplastics (less than 0.01 mm) and nanoplastics (much smaller than microplastics) are tiny plastic particles found in water, food, and even the air. Studies suggest they can enter the body quite readily especially when they are 100 nanometers or smaller.

The probiotic source, Qi6, used in Qi601 has been reviewed and approved as Generally Recognized As Safe (GRAS) by the U.S. Food and Drug Administration under GRN No. 00988.

Qi601 is not a drug—it doesn’t act on your body like a medicine. It’s a non-pharmacological, physical agent, supplement designed to safely bind up microplastics.

That depends on your exposure and usage goals. While it may be safe for regular use, specific dosing would be guided by future product recommendations and ongoing in human use testing.

Qi601’s safety profile is promising, but as with any supplement, it should only be used under guidance from a healthcare provider—especially in children, during pregnancy, or while breastfeeding.

No. Qi601 is an inactivated probiotic and does not interfere with your natural microbiome. It doesn’t colonize or change your gut flora—it simply binds up plastic particles.

U.S. Patent Coverage: Biofilm Cellular Mass for Barrier ProtectionThe unique manufacturing process that induces a biofilm phenotype and a biofilm cellular mass in all probiotics is protected under Quorum Innovations’ issued patents. This extends the company’s issued patented rights beyond Qi601, encompassing a class of microbiome-based therapeutics for protecting human barriers.and environmental sequestration agents designed around this patented principle. Biofilm probiotic phenotype across all strains are covered with over 50 patents issued in the Untied States and Internationally including the European Union via the via The Patent Cooperation Treaty (PCT) , China, Japan, Israel, Korea, South American Countries. 

Qi601 is available on our ecommerce site Qi601.com

Frequently asked questions

Can’t find what you are looking for? Our people are here to help you?